Tag Archives: FGEN

Top Safest Stocks To Own For 2019

The anxiety, frustration and second-guessing builds during times like these, but you must remain vigilant and, more important, patient.

Since the market peaked at the end of January and subsequently slid into its first correction in two years, we’ve been patiently waiting to see whether this is “just” a correction or if it’s the start of the next bear market.

—Recommended Link— The Most Generous Income Producers You Can Get
We’re sitting on a collection of the safest, most generous monthly payers available. And while $11,200 in dividend checks is a welcome addition to anyone’s income, investors also love racking up capital gains as high as 446%.Start generating a 10%+ income stream for life today from these consistent companies.

But as the market consolidates before its next move, the anticipation can be almost too much for many investors. In times like these, mistakes are made and money is lost. Investing strategies and discipline get tossed out the window as traders base their next move on the daily swings of the market. Euphoria climbs when the S&P 500 ends the day in green, but it quickly fades the next day when the market opens lower.

Top Safest Stocks To Own For 2019: Viking Therapeutics, Inc.(VKTX)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Viking Therapeutics (NASDAQ:VKTX) jumped nearly 14% today after Gilead Sciences (NASDAQ:GILD) announced that a closely watched drug candidate failed a phase 3 trial. The drug candidate, selonsertib, was being developed as a potential treatment for nonalcoholic steatohepatitis (NASH).

  • [By Money Morning News Team]

    While exciting, CODX and our other penny stocks to watch this week are unlikely to tack on any additional gains this week. But don’t worry. After looking at our 10 top penny stocks to watch, we’ll show you a stock with serious profit potential in its future…

    Penny Stock Current Share Price Last Week’s Gain
    Co-Diagnostics Inc. (Nasdaq: CODX)  $4.35 192.07%
    Viking Therapeutics Inc. (Nasdaq: VKTX)  $9.37 95.78%
    DHI Group Inc. (NYSE: DHX)  $3.10 67.57%
    Axovant Sciences Ltd. (Nasdaq: AXON)  $1.76 60.00%
    Netlist Inc. (Nasdaq: NLST)  $0.21 53.79%
    Link Motion Inc. (NYSE LKM)  $1.23 47.73%
    CorMedix Inc. (NYSE: CRMD)  $0.26 44.44%
    Vistagen Therapeutics Inc. (Nasdaq: VTGN)  $1.34 40.21%
    J. Jill Inc. (NYSE: JILL)  $8.30 36.55%
    Adomani Inc. (Nasdaq: ADOM)  $1.52 34.86%

    In order to make sure we protect ourselves from any substantial losses from investing in penny stocks, we follow five rules for penny stock investing. Take look at them on the right.As these stocks demonstrate, there are penny stocks that have tremendous growth potential that can easily dwarf your initial investment. However, most penny stocks lack the solid underlying financials necessary to generate a significant return.
    Fast Money: This powerful secret made one man a millionaire. Now he’s sharing it live on camera – find out how you could use it to become $2,918 richer in less than a minute. Click here…

  • [By Todd Campbell, Keith Speights, and Brian Feroldi]

    Investing in biotech stocks can be risky because clinical trial failures can lead to eye-popping drops in share prices. Nevertheless, the potential to benefit from revolutionary new medicines can make owning biotech stocks in a diversified portfolio smart. If you’re hunting for new biotech stocks to buy, these three Motley Fool investors think you should consider Ligand Pharmaceuticals (NASDAQ:LGND), Viking Therapeutics (NASDAQ:VKTX), and Amarin Corporation (NASDAQ:AMRN). Each of these companies has catalysts that could make now a good time to pick up shares.

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c

Top Safest Stocks To Own For 2019: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By Max Byerly]

    Hilltop Holdings Inc. lifted its holdings in shares of FibroGen Inc (NASDAQ:FGEN) by 2.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 55,140 shares of the biopharmaceutical company’s stock after buying an additional 1,530 shares during the period. FibroGen makes up approximately 0.7% of Hilltop Holdings Inc.’s holdings, making the stock its 22nd largest position. Hilltop Holdings Inc. owned approximately 0.07% of FibroGen worth $3,452,000 as of its most recent filing with the SEC.

  • [By Shane Hupp]

    FibroGen (NASDAQ:FGEN) was upgraded by analysts at ValuEngine from a buy rating to a strong-buy rating.

    Fulgent Genetics (NASDAQ:FLGT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $5.25 price target on the stock. According to Zacks, “Fulgent Genetics, Inc. is a technology company. It provide genetic testing services to physicians with clinically actionable diagnostic information. The Company’s technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics, Inc. is headquartered in Temple City, California. “

  • [By Ethan Ryder]

    FibroGen (NASDAQ:FGEN) Director Jorma Routti sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The shares were sold at an average price of $47.10, for a total transaction of $282,600.00. Following the completion of the transaction, the director now directly owns 133,840 shares in the company, valued at approximately $6,303,864. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

  • [By Logan Wallace]

    FibroGen (NASDAQ:FGEN) was downgraded by equities researchers at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Thursday.

Top Safest Stocks To Own For 2019: Provident Financial Holdings, Inc.(PROV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    E*TRADE Financial (NASDAQ: ETFC) and Provident Financial (NASDAQ:PROV) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings and dividends.

  • [By Logan Wallace]

    Charter Financial (NASDAQ: CHFN) and Provident Financial (NASDAQ:PROV) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

  • [By Max Byerly]

    News articles about Provident Financial (NASDAQ:PROV) have been trending somewhat negative this week, according to Accern. Accern identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Provident Financial earned a daily sentiment score of -0.02 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 45.9215692366566 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top Safest Stocks To Own For 2019: El Pollo Loco Holdings, Inc.(LOCO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    ValuEngine upgraded shares of El Pollo LoCo (NASDAQ:LOCO) from a strong sell rating to a sell rating in a report issued on Tuesday.

    Several other research firms also recently weighed in on LOCO. BidaskClub upgraded El Pollo LoCo from a sell rating to a hold rating in a research report on Friday, June 22nd. SunTrust Banks set a $11.00 target price on El Pollo LoCo and gave the company a hold rating in a research report on Thursday, March 8th. Finally, Morgan Stanley restated an equal weight rating and issued a $11.00 target price (down previously from $12.00) on shares of El Pollo LoCo in a research report on Monday, March 12th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company’s stock. El Pollo LoCo has a consensus rating of Hold and a consensus target price of $12.40.

  • [By Dan Caplinger]

    Wall Street finished the week on a low note on Friday, dealing another losing day to investors already hard-hit from declines in previous trading sessions. Today’s culprit was a poor labor report, which showed that the U.S. economy produced only 20,000 new nonfarm payroll jobs during the month of February. Many stocks suffered much more dramatic losses than the roughly 0.1% to 0.2% decline that major indexes saw, with earnings playing a key role for several of them. American Outdoor Brands (NASDAQ:AOBC), Eventbrite (NYSE:EB), and El Pollo Loco Holdings (NASDAQ:LOCO) were among the worst performers. Here’s why they did so poorly.

  • [By Motley Fool Transcribers]

    El Pollo Loco Holdings Inc  (NASDAQ:LOCO)Q4 2018 Earnings Conference CallMarch 07, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Nathan’s Famous (NASDAQ: NATH) and El Pollo LoCo (NASDAQ:LOCO) are both small-cap retail/wholesale companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Top Safest Stocks To Own For 2019: Cresud S.A.C.I.F. y A.(CRESY)

Advisors’ Opinion:

  • [By Max Byerly]

    Media headlines about Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) have been trending somewhat positive recently, Accern reports. The research group identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cresud S.A.C.I.F. y A. earned a coverage optimism score of 0.20 on Accern’s scale. Accern also assigned headlines about the company an impact score of 46.7755181744414 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Stephan Byrd]

    News coverage about Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cresud S.A.C.I.F. y A. earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned news stories about the company an impact score of 47.6414670877177 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Shane Hupp]

    Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 294,367 shares, a decline of 44.8% from the April 30th total of 533,376 shares. Based on an average daily volume of 179,726 shares, the days-to-cover ratio is presently 1.6 days.

Hot Blue Chip Stocks To Watch For 2019

Inverness Counsel LLC NY trimmed its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 3.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 222,754 shares of the healthcare conglomerate’s stock after selling 7,191 shares during the quarter. UnitedHealth Group comprises 3.1% of Inverness Counsel LLC NY’s investment portfolio, making the stock its 6th biggest holding. Inverness Counsel LLC NY’s holdings in UnitedHealth Group were worth $54,650,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. Welch Group LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $106,000. Blue Chip Partners Inc. acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $107,000. Bamco Inc. NY acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $117,000. Northwest Wealth Management LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $117,000. Finally, Bruderman Asset Management LLC acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $134,000. 85.17% of the stock is owned by institutional investors.

Hot Blue Chip Stocks To Watch For 2019: NTN Buzztime, Inc.(NTN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

    Get Pacific Ethanol alerts:

    Price to Earnings Ratio in the Spotlight – Pacific Ethanol Inc (NASDAQ: PEIX) (stocksmarketcap.com) Where Relative Volume Stands? – Pacific Ethanol Inc (NASDAQ: PEIX) (stockspen.com) Hot Stock’s Trend Recap – Pacific Ethanol Inc. (NASDAQ: PEIX) (financerater.com) Global Biorefinery Market 2018 Outlook and Growth by 2023: Pacific Ethanol, Renewable Energy Group Inc, Abengoa … (thecleantechnology.com) Volume Movers: Jones Energy, Inc. (NYSE:JONE), Pacific Ethanol, Inc. (NASDAQ:PEIX), NTN Buzztime, Inc. (NYSE:NTN) (stocksnewspoint.com)

    NASDAQ PEIX traded down $0.05 during trading hours on Thursday, reaching $3.10. The company’s stock had a trading volume of 201,540 shares, compared to its average volume of 407,376. The stock has a market capitalization of $141.29 million, a price-to-earnings ratio of -3.65 and a beta of 2.03. Pacific Ethanol has a 1-year low of $2.75 and a 1-year high of $7.50. The company has a current ratio of 2.24, a quick ratio of 1.51 and a debt-to-equity ratio of 0.61.

Hot Blue Chip Stocks To Watch For 2019: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Verde Servicos Internacionais S.A. reduced its holdings in shares of FibroGen Inc (NASDAQ:FGEN) by 12.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 8,922 shares of the biopharmaceutical company’s stock after selling 1,315 shares during the period. Verde Servicos Internacionais S.A.’s holdings in FibroGen were worth $558,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    FibroGen (NASDAQ:FGEN) was upgraded by analysts at ValuEngine from a buy rating to a strong-buy rating.

    Fulgent Genetics (NASDAQ:FLGT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $5.25 price target on the stock. According to Zacks, “Fulgent Genetics, Inc. is a technology company. It provide genetic testing services to physicians with clinically actionable diagnostic information. The Company’s technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics, Inc. is headquartered in Temple City, California. “

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on FibroGen (FGEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Hilltop Holdings Inc. lifted its holdings in shares of FibroGen Inc (NASDAQ:FGEN) by 2.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 55,140 shares of the biopharmaceutical company’s stock after buying an additional 1,530 shares during the period. FibroGen makes up approximately 0.7% of Hilltop Holdings Inc.’s holdings, making the stock its 22nd largest position. Hilltop Holdings Inc. owned approximately 0.07% of FibroGen worth $3,452,000 as of its most recent filing with the SEC.

Hot Blue Chip Stocks To Watch For 2019: Seacoast Banking Corporation of Florida(SBCF)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Seacoast Banking Co. of Florida (SBCF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Seacoast Banking Co. of Florida (SBCF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    BidaskClub cut shares of Seacoast Banking Co. of Florida (NASDAQ:SBCF) from a hold rating to a sell rating in a research note released on Wednesday.

  • [By Max Byerly]

    Media headlines about Seacoast Banking Co. of Florida (NASDAQ:SBCF) have trended somewhat positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Seacoast Banking Co. of Florida earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned news coverage about the financial services provider an impact score of 46.6820292106654 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Hot Blue Chip Stocks To Watch For 2019: Alpine Total Dynamic Dividend Fund(AOD)

Advisors’ Opinion:

  • [By Logan Wallace]

    Oppenheimer & Co. Inc. lifted its stake in shares of Alpine Total Dynamic Div (NYSE:AOD) by 14.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 101,451 shares of the investment management company’s stock after acquiring an additional 12,551 shares during the period. Oppenheimer & Co. Inc. owned 0.09% of Alpine Total Dynamic Div worth $906,000 as of its most recent SEC filing.

Hot Blue Chip Stocks To Watch For 2019: Globus Medical, Inc.(GMED)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Globus Medical Inc  (NYSE:GMED)Q4 2018 Earnings Conference CallFeb. 21, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Globus Medical Inc (NYSE:GMED) – Research analysts at William Blair cut their Q2 2018 earnings per share (EPS) estimates for shares of Globus Medical in a report released on Thursday, May 3rd. William Blair analyst K. Krum now forecasts that the medical device company will earn $0.35 per share for the quarter, down from their previous estimate of $0.37. William Blair also issued estimates for Globus Medical’s Q3 2018 earnings at $0.35 EPS, FY2018 earnings at $1.52 EPS, Q1 2019 earnings at $0.42 EPS, Q3 2019 earnings at $0.42 EPS, Q4 2019 earnings at $0.46 EPS and FY2019 earnings at $1.71 EPS.

  • [By Joseph Griffin]

    Hill-Rom (NYSE:HRC) and Globus Medical (NYSE:GMED) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

  • [By Logan Wallace]

    Penumbra (NYSE: PEN) and Globus Medical (NYSE:GMED) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, risk, profitability and valuation.

  • [By Ethan Ryder]

    Northern Trust Corp raised its holdings in shares of Globus Medical Inc (NYSE:GMED) by 2.9% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,190,383 shares of the medical device company’s stock after acquiring an additional 33,264 shares during the quarter. Northern Trust Corp’s holdings in Globus Medical were worth $60,067,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Several analysts have issued reports on GMED shares. Morgan Stanley lowered shares of Globus Medical from an overweight rating to an equal weight rating and decreased their price target for the stock from $64.00 to $49.00 in a research report on Wednesday, January 2nd. ValuEngine lowered shares of Globus Medical from a strong-buy rating to a buy rating in a research report on Wednesday, November 28th. Cantor Fitzgerald set a $60.00 price target on shares of Globus Medical and gave the stock a buy rating in a research report on Friday, January 18th. Zacks Investment Research lowered shares of Globus Medical from a buy rating to a hold rating in a research report on Tuesday, January 8th. Finally, UBS Group began coverage on shares of Globus Medical in a research report on Wednesday, November 28th. They set a neutral rating and a $55.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and an average price target of $56.08.

    TRADEMARK VIOLATION NOTICE: “Globus Medical (GMED) Releases FY 2019 Earnings Guidance” was posted by Ticker Report and is the property of of Ticker Report. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at www.tickerreport.com/banking-finance/4169557/globus-medical-gmed-releases-fy-2019-earnings-guidance.html.

    Globus Medical Company Profile

Top 5 Low Price Stocks To Buy For 2019

Following past boom/bust cycles, the oil business appears to have bottomed in February 2016 at $27 a barrel. The bruising multi-year bust in crude oil prices was the biggest reason for the world stock market sell-off from late 2015 to early 2016 of roughly 15% overall. The cruel irony of ultra-low prices is its disruptive effect on regular exploration activity. A short-term oil market depression in expectations disproportionately slashes oil drilling activity. Oil exploration budgets for 2017 are down 65% from 2014 and the smallest in 12 years, DESPITE a record estimate for global demand next year. In the long-run, oil & gas development and production may fail to keep pace with the steady growth in total demand. Will the 2015-16 “bust” sow the seeds of the next “boom” phase in pricing?

Click to enlarge

Top 5 Low Price Stocks To Buy For 2019: Bunge Limited(BG)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Burren Capital Advisors Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Burren+Capital+Advisors+Ltd

    These are the top 5 holdings of Burren Capital Advisors LtdMonsanto Co (MON) – 77,300 shares, 36.53% of the total portfolio. Shares added by 26.41%NXP Semiconductors NV (NXPI) – 49,500 shares, 23.46% of the total portfolio. New PositionDell-VMWare Tracking Stock (DVMT) – 57,930 shares, 17.17% of the total portfolio. Shares added by 5.52%Time Warner Inc (TWX) – 30,800 shares, 11.8% of the total portfolio. Shares added by 3.77%Bunge Ltd (BG) – 25,050 shares, 7.5% of

  • [By Stephan Byrd]

    Bunge Ltd (NYSE:BG) insider Jerry Matthews Simmons, Jr. sold 4,122 shares of the business’s stock in a transaction on Monday, June 4th. The stock was sold at an average price of $70.30, for a total value of $289,776.60. Following the completion of the sale, the insider now directly owns 10,068 shares in the company, valued at approximately $707,780.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

  • [By Jon C. Ogg]

    Bunge Ltd. (NYSE: BG) has often been considered a global proxy for the price and trade issues around soybeans. Its shares were actually down 14 cents at $67.85 late Thursday morning (after opening up at $68.10). The 52-week range is $63.87 to $83.20, and the consensus target price is $86.70. That consensus target seems quite generous considering the major price slide that has been seen since February.

  • [By Zacks]

    It goes without saying that companies that export huge amounts of farm products to China stand to be the winners. Shares of The Andersons, Inc. (NASDAQ: ANDE) jumped 1.6%, while Bunge Limited (NYSE: BG) increased 0.4% on Monday.

Top 5 Low Price Stocks To Buy For 2019: ASML Holding N.V.(ASML)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on ASML (ASML)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    ASML (NASDAQ: ASML) and ACM Research (NASDAQ:ACMR) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

  • [By Ethan Ryder]

    Dubuque Bank & Trust Co. decreased its position in shares of ASML Holding NV (NASDAQ:ASML) by 28.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,760 shares of the semiconductor company’s stock after selling 3,855 shares during the quarter. Dubuque Bank & Trust Co.’s holdings in ASML were worth $1,938,000 at the end of the most recent quarter.

Top 5 Low Price Stocks To Buy For 2019: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Verde Servicos Internacionais S.A. reduced its holdings in shares of FibroGen Inc (NASDAQ:FGEN) by 12.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 8,922 shares of the biopharmaceutical company’s stock after selling 1,315 shares during the period. Verde Servicos Internacionais S.A.’s holdings in FibroGen were worth $558,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    FibroGen (NASDAQ:FGEN) Director Jorma Routti sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The shares were sold at an average price of $47.10, for a total transaction of $282,600.00. Following the completion of the transaction, the director now directly owns 133,840 shares in the company, valued at approximately $6,303,864. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on FibroGen (FGEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Low Price Stocks To Buy For 2019: Regions Financial Corporation(RF)

Advisors’ Opinion:

  • [By ]

    In the Lightning Round, Cramer was bullish on Align Technology (ALGN) , Regions Financial (RF) , Edwards Lifesciences (EW) , Qualys (QLYS) and HEICO (HEI) .

  • [By ]

    Regions Financial (NYSE: RF) could be a beneficiary of the move to deregulation in banking this year and is expected to grow earnings by 24% to $1.35 per share. The bank is seeing strong growth in non-interest income sources and management has a plan to cut up to 10% in operating expenses for greater profitability. Regions has a strong deposit base across the Southeast and averages a 7% return on equity, well above the industry average.

  • [By ]

    Regions Financial (RF) : “I think this one is real good. I like the banks here.”

    Edwards Lifesciences (EW) : “They have the best devices. That stock is a buy.”

Top 5 Low Price Stocks To Buy For 2019: Ormat Technologies, Inc.(ORA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

  • [By Shane Hupp]

    JPMorgan Chase lowered shares of Ormat Technologies (NYSE:ORA) from an overweight rating to a neutral rating in a research note issued to investors on Monday, MarketBeat.com reports. They currently have $62.00 price target on the energy company’s stock.

  • [By Ethan Ryder]

    Orange (EPA:ORA) received a €16.50 ($19.19) price target from Credit Suisse Group in a research note issued to investors on Wednesday. The firm currently has a “buy” rating on the stock. Credit Suisse Group’s price target indicates a potential upside of 17.61% from the stock’s previous close.

Best Stocks To Buy For 2019

Amundi Pioneer Asset Management Inc. lifted its position in M&T Bank Co. (NYSE:MTB) by 17.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 241,374 shares of the financial services provider’s stock after buying an additional 35,785 shares during the quarter. Amundi Pioneer Asset Management Inc. owned about 0.17% of M&T Bank worth $44,499,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in MTB. Victory Capital Management Inc. grew its stake in shares of M&T Bank by 9.8% in the fourth quarter. Victory Capital Management Inc. now owns 18,045 shares of the financial services provider’s stock valued at $3,086,000 after buying an additional 1,612 shares in the last quarter. First Trust Advisors LP grew its stake in shares of M&T Bank by 31.1% in the fourth quarter. First Trust Advisors LP now owns 206,182 shares of the financial services provider’s stock valued at $35,255,000 after buying an additional 48,938 shares in the last quarter. Advisory Services Network LLC grew its stake in shares of M&T Bank by 3,020.3% in the fourth quarter. Advisory Services Network LLC now owns 3,682 shares of the financial services provider’s stock valued at $630,000 after buying an additional 3,564 shares in the last quarter. Rhumbline Advisers grew its stake in shares of M&T Bank by 0.8% in the fourth quarter. Rhumbline Advisers now owns 265,868 shares of the financial services provider’s stock valued at $45,461,000 after buying an additional 2,213 shares in the last quarter. Finally, Tower Research Capital LLC TRC bought a new position in shares of M&T Bank in the fourth quarter valued at $204,000. 78.84% of the stock is owned by institutional investors and hedge funds.

Best Stocks To Buy For 2019: SuperCom, Ltd.(SPCB)

Advisors’ Opinion:

  • [By Shane Hupp]

    Supercom (NASDAQ:SPCB) shares reached a new 52-week high and low during trading on Wednesday . The company traded as low as $1.84 and last traded at $1.92, with a volume of 980 shares traded. The stock had previously closed at $1.92.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

  • [By Alexander Bird]

    Here are the top performers from last week…

    Penny Stock Current Share Price Last Week’s Gain
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $1.83 165.71%
    Radisys Corp. (Nasdaq: RSYS) $1.55 115.68%
    Ascent Capital Group Inc. (Nasdaq: ASCMA) $3.71 43.12%
    Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) $4.36 40.63%
    Tintri Inc. (Nasdaq: TNTR) $0.18 40.49%
    Prana Biotechnology Ltd. (Nasdaq: PRAN) $2.35 39.96%
    Micronet Enertec Technologies Inc. (Nasdaq: MICT) $1.60 39.40%
    Corindus Vascular Robotics (NYSE: CVRS) $1.17 34.40%
    ParkerVision Inc. (Nasdaq: PRKR) $0.70 30.65%
    SuperCom Ltd. (Nasdaq: SPCB) $0.24 30.10%

    While these gains are exciting, they pale in comparison to the profit potential of our top penny stock to buy this week.

Best Stocks To Buy For 2019: Broadwind Energy Inc.(BWEN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Matthews International (NASDAQ: MATW) and Broadwind Energy (NASDAQ:BWEN) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends.

  • [By Ethan Ryder]

    Matthews International (NASDAQ: MATW) and Broadwind Energy (NASDAQ:BWEN) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Best Stocks To Buy For 2019: SemiLEDS Corporation(LEDS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55.
    EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363.
    Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy.
    Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose
  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares jumped 104.82 percent to close at $14.87 on Tuesday.
    EVINE Live Inc. (NASDAQ: EVLV) rose 31.25 percent to close at $1.06. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    SemiLEDs Corporation (NASDAQ: LEDS) shares climbed 27.16 percent to close at $4.26 on Tuesday.
    Atossa Genetics Inc. (NASDAQ: ATOS) gained 27.09 percent to close at $3.80. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) surged 17.13 percent to close at $37.95 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares gained 15.91 percent to close at $18.21 following upbeat quarterly earnings.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares jumped 15.73 percent to close at $7.58 on Tuesday after declining 1.50 percent on Monday.
    Sanmina Corp (NASDAQ: SANM) shares gained 14.62 percent to close at $31.75 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Orchids Paper Products Company (NYSE: TIS) jumped 12.86 percent to close at $7.37. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) rose 12.8 percent to close at $7.05 following strong quarterly results.
    Avid Bioservices, Inc. (NASDAQ: CDMO) rose 12.72 percent to close at $3.81.
    Genprex, Inc. (NASDAQ: GNPX) gained 12.61 percent to close at $5.00.
    Obalon Therapeutics, Inc. (NASDAQ: OBLN) rose 12.39 percent to close at $3.72.
    NextDecade Corporation (NASDAQ: NEXT) shares climbed 11.88 percent to close at $7

Best Stocks To Buy For 2019: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on FibroGen (FGEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    FibroGen (NASDAQ:FGEN) Director Jorma Routti sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The shares were sold at an average price of $47.10, for a total transaction of $282,600.00. Following the completion of the transaction, the director now directly owns 133,840 shares in the company, valued at approximately $6,303,864. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

  • [By Stephan Byrd]

    Verde Servicos Internacionais S.A. reduced its holdings in shares of FibroGen Inc (NASDAQ:FGEN) by 12.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 8,922 shares of the biopharmaceutical company’s stock after selling 1,315 shares during the period. Verde Servicos Internacionais S.A.’s holdings in FibroGen were worth $558,000 at the end of the most recent quarter.

Top 10 Low Price Stocks To Buy Right Now

If you are in retirement, you’re probably looking for conservative, long-term stocks that offer notable income. International energy giant ExxonMobil Corporation (NYSE:XOM) fits that bill. The best part today is that investors have put this energy giant’s stock on sale. Here’s why Exxon is a retiree’s dream stock right now.

A tough run opens up an opportunity

ExxonMobil stock has underperformed over the past year or so. The stock is down around 6% in the last 12 months, while most of its major competitors are up 20% or more. Peer Royal Dutch Shellis up a huge 33%! While it might be easy to suggest that Exxon has lost its way and should be avoided in favor of other oil majors executing better today, that would be a mistake. Exxon’s low price has created an opportunity for retirees.

Image source: Getty Images.

Top 10 Low Price Stocks To Buy Right Now: ClearBridge Energy MLP Total Return Fund Inc.(CTR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.

  • [By Joseph Griffin]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.

  • [By Joseph Griffin]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.

Top 10 Low Price Stocks To Buy Right Now: Wipro Limited(WIT)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to

Top 10 Low Price Stocks To Buy Right Now: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    FibroGen (NASDAQ:FGEN) Director Jorma Routti sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The shares were sold at an average price of $47.10, for a total transaction of $282,600.00. Following the completion of the transaction, the director now directly owns 133,840 shares in the company, valued at approximately $6,303,864. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Top 10 Low Price Stocks To Buy Right Now: Microchip Technology Incorporated(MCHP)

Advisors’ Opinion:

  • [By Lee Jackson]

    This company is a huge Internet of Things benefactor. Microchip Technology Inc. (NASDAQ: MCHP) is a leading provider of microcontroller, mixed-signal, analog and flash-IP solutions, providing low-risk product development, lower total system cost and faster time to market for thousands of diverse customer applications worldwide.

  • [By Shane Hupp]

    Mar Vista Investment Partners LLC bought a new stake in Microchip Technology (NASDAQ:MCHP) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 888,437 shares of the semiconductor company’s stock, valued at approximately $81,168,000. Microchip Technology comprises 3.2% of Mar Vista Investment Partners LLC’s investment portfolio, making the stock its 12th largest position.

  • [By Stephan Byrd]

    Microchip Technology (NASDAQ:MCHP) had its price objective increased by Morgan Stanley from $96.00 to $97.00 in a research report report published on Wednesday morning. The brokerage currently has an equal weight rating on the semiconductor company’s stock.

  • [By ]

    Though concerns have been raised that the analog and MCU markets are at risk of seeing an inventory correction (they haven’t had a major one in a while), given signs of excessive ordering and stretched lead times, TI and STMicro’s numbers suggest conditions remain good for now. That’s particularly true in industrial and auto markets where trends such as factory automation, ADAS adoption and electric/hybrid car sales are boosting chip demand. Several other analog/MCU firms, including Microchip (MCHP) , ON Semiconductor (ON) , Maxim Integrated (MXIM) and NXP Semiconductors (NXPI) , will be reporting soon.

  • [By ]

    Crutcher added that TI’s own chip manufacturing teams have been pushing equipment suppliers to make their machinery smarter. “We want it to tell us sooner if there’s an issue with the [chip] wafer that’s going through that machine,” he said as an example. Fellow analog chip and microcontroller (MCU) suppliers such as Analog Devices (ADI) and Microchip (MCHP) also have strong industrial exposure.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o

Top 10 Low Price Stocks To Buy Right Now: Teradyne, Inc.(TER)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Teradyne, Inc. (NYSE: TER) fell 10.8 percent to $37.02 in pre-market trading after the company issued downbeat Q2 guidance.
    Edwards Lifesciences Corporation (NYSE: EW) fell 9.2 percent to $122.29 in pre-market trading. Edwards Lifesciences reported better-than-expected results for its first quarter, but issued weak earnings guidance for the second quarter.
    New Gold Inc. (NYSE: NGD) fell 8.8 percent to $2.30 in pre-market trading after rising 4.13 percent on Tuesday.
    Gold Fields Limited (ADR) (NYSE: GFI) fell 8.6 percent to $3.61 in pre-market trading.
    Natus Medical Incorporated (NASDAQ: BABY) fell 8.2 percent to $32.95 in pre-market trading after the company issued weak forecast for the second quarter.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 7.9 percent to $3.50 in pre-market trading after climbing 27.09 percent on Tuesday.
    Bright Scholar Education Holdings Limited (NYSE: BEDU) shares fell 6.7 percent to $13.58 in pre-market trading after reporting Q1 results.
    Sangamo Therapeutics Inc (NASDAQ: SGMO) fell 5.9 percent to $16.75 in pre-market trading following announcement of a $200 million common stock offering.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) shares fell 5.7 percent to $3.29 in pre-market trading after declining 3.32 percent on Tuesday.
    Euronav NV (NYSE: EURN) fell 4.8 percent to $8.40 in pre-market trading.
    Limelight Networks, Inc. (NASDAQ: LLNW) shares fell 4.3 percent to $4.69 in pre-market trading.
    Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 4.1 percent to $32.92 in pre-market trading after the company issued downbeat quarterly results and reported the retirement of CFO William Clifford

  • [By Lisa Levin]

    Shares of Teradyne, Inc. (NYSE: TER) were down 16 percent to $34.6801 after the company issued downbeat Q2 guidance.

    HFF, Inc. (NYSE: HF) was down, falling around 18 percent to $38.805 following weaker-than-expected quarterly results.

  • [By Dan Caplinger]

    Wednesday was an up-and-down day on Wall Street. Major benchmarks started the day sharply lower as concerns about rising interest rates continued to swirl among those following the financial markets. Investors then seemed to get more comfortable with the current state of affairs, leading to a rebound, but further volatility left the Dow with only modest gains by the end of the session. Some bad news from key companies also weighed on overall sentiment. Snap (NYSE:SNAP), Teradyne (NYSE:TER), and Owens Corning (NYSE:OC) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Low Price Stocks To Buy Right Now: Qualys, Inc.(QLYS)

Advisors’ Opinion:

  • [By ]

    Qualys (QLYS) : “I think this is a good company, but everything is coming down, so let’s wait to buy some more.”

    HEICO (HEI) : “We’re not buying anything at a 52-week high — but on a pullback, you bet.”

  • [By ]

    In the Lightning Round, Cramer was bullish on Align Technology (ALGN) , Regions Financial (RF) , Edwards Lifesciences (EW) , Qualys (QLYS) and HEICO (HEI) .

Top 10 Low Price Stocks To Buy Right Now: Chesapeake Utilities Corporation(CPK)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Anheuser-Busch InBev SA/NV (NYSE: BUD) is estimated to report quarterly earnings at $0.89 per share on revenue of $13.06 billion.
    SINA Corporation (NASDAQ: SINA) is expected to report quarterly earnings at $0.42 per share on revenue of $433.32 million.
    Weibo Corporation (NASDAQ: WB) is projected to report quarterly earnings at $0.47 per share on revenue of $342.39 million.
    Ameren Corporation (NYSE: AEE) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.55 billion.
    Mylan N.V. (NASDAQ: MYL) is projected to report quarterly earnings at $0.98 per share on revenue of $2.75 billion.
    Cinemark Holdings, Inc. (NYSE: CNK) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.51 billion.
    ADT Inc. (NYSE: ADT) is expected to report quarterly earnings at $0.24 per share on revenue of $1.11 billion.
    Coty Inc. (NYSE: COTY) is projected to report quarterly earnings at $0.13 per share on revenue of $2.18 billion.
    Pinnacle Entertainment, Inc. (NYSE: PNK) is estimated to report quarterly earnings at $0.31 per share on revenue of $644.94 million.
    Conduent Incorporated (NYSE: CNDT) is estimated to report quarterly earnings at $0.21 per share on revenue of $1.44 billion.
    Delphi Technologies PLC (NYSE: DLPH) is projected to report quarterly earnings at $1.16 per share on revenue of $1.25 billion.
    Office Depot, Inc. (NASDAQ: ODP) is expected to report quarterly earnings at $0.08 per share on revenue of $2.72 billion.
    Global Partners LP (NYSE: GLP) is estimated to report quarterly earnings at $0.13 per share on revenue of $2.33 billion.
    Wolverine World Wide, Inc. (NYSE: WWW) is projected to report quarterly earnings at $0.37 per share on revenue of $530.99 million.
    Performance Food Group Company (NYSE: PFGC) is expected to report quarterly earnings at $0.32 per share on revenue of $4.46 billion.
    Groupon, Inc. (NASDAQ: GRPN) is projected to report

Top 10 Low Price Stocks To Buy Right Now: Cimpress N.V(CMPR)

Advisors’ Opinion:

  • [By Logan Wallace]

    SunTrust Banks reaffirmed their hold rating on shares of Cimpress (NASDAQ:CMPR) in a research note published on Tuesday. SunTrust Banks currently has a $144.00 price objective on the business services provider’s stock.

  • [By Joseph Griffin]

    Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

    Get Cimpress alerts:

    Cimpress (CMPR) Earns Hold Rating from SunTrust Banks (americanbankingnews.com) Katryn Blake Sells 9,297 Shares of Cimpress (CMPR) Stock (americanbankingnews.com) Insider Selling: Cimpress (CMPR) CEO Sells 4,648 Shares of Stock (americanbankingnews.com) Cimpress’ (CMPR) “Sell” Rating Reiterated at Aegis (americanbankingnews.com) Cimpress (CMPR) Given Consensus Rating of “Hold” by Brokerages (americanbankingnews.com)

    A number of equities analysts recently weighed in on the company. SunTrust Banks reaffirmed a “hold” rating and issued a $144.00 price target on shares of Cimpress in a report on Tuesday. ValuEngine raised Cimpress from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd. Aegis reaffirmed a “sell” rating and issued a $114.00 price target on shares of Cimpress in a report on Tuesday. BidaskClub cut Cimpress from a “buy” rating to a “hold” rating in a report on Friday, May 4th. Finally, Barrington Research reaffirmed a “buy” rating and issued a $165.00 price target on shares of Cimpress in a report on Tuesday, May 1st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $140.00.

  • [By Steve Symington]

    Cimpress NV(NASDAQ:CMPR)announced fiscal third-quarter 2018 results on Wednesday after the market closed, detailing the continued fruits of last year’s Vistaprint restructuring and steady growth at each of its three core business segments.Still, shares of the mass customization specialist were down on Thursday in response to the news.

Top 10 Low Price Stocks To Buy Right Now: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Leo Sun]

    Shares of Fitbit (NYSE:FIT) plunged 12% toan all-time low after the wearables maker posted its first quarter numbers. The company beat Wall Street’s low expectations, but its guidance for the current quarter calls for steeper revenue declines and wider losses.

  • [By Brian Withers]

    Just when Fitbit (NYSE:FIT) investors were hoping for a glimmer of good news in the company’s fourth quarter earnings report, it seems this wearable device maker’s turnaround has stalled.

  • [By Harsh Chauhan]

    Fitbit (NYSE:FIT) has been paying a big price for being late to the smartwatch game. The company missed the shift in consumer preferences and surrendered its lead in the wearables market to a big shark like Apple, which didn’t waste much time in stamping its authority on this still-growing space.

  • [By Paul Ausick]

    Fitbit Inc. (NYSE: FIT) traded down nearly 16% Tuesday and posted a new 52-week low of $4.67 after closing Monday at $5.54. The stock’s 52-week high is $7.32. Volume was more than six times the daily average of 5.4 million shares. The company reported poor results last night and offered up weak guidance as a side dish. 247wallst.com/consumer-electronics/2018/02/26/fitbit-whiffs-big-on-earnings-and-even-bigger-on-guidance/

  • [By Chris Hill]

    In this MarketFoolery podcast, host Chris Hill and David Kretzmann of Motley Fool Rule Breakers and Supernova discuss Tesla’s(NASDAQ:TSLA) first quarter — yes, Model 3 production is still lagging — and Elon Musk’s odd behavior on the company’s conference call; Spotify’s(NYSE:SPOT) first post-IPO quarterly report, which was a reminder of how hard it can be in tech to transition into the harsh glare of the public markets; and the future of struggling wearables icon Fitbit(NYSE:FIT).

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 10 Low Price Stocks To Buy Right Now: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.07. Investors who bought at $2.55 are sitting on a 58% loss today (Jan. 8).

  • [By Money Morning Staff Reports]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.19. Investors who bought at $2.55 are sitting on a 53.3% loss today (Feb. 20).

  • [By Money Morning News Team]

    For example, the VistaGen Therapeutics Inc.(Nasdaq: VTGN) stock price soared from $0.92 to $2.55 on Dec. 6, 2017.

    Less than two weeks later, the share price plummeted back to $1.05, which would be a 58% loss for anyone who bought at the peak.

  • [By Money Morning News Team]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up 177%, from $0.92 to $2.55, on Dec. 6, when it announced it won a patent for its CNS treatment.